Josh Barnett — who recently failed a pre-fight drug screening for anabolic steroids prior to a showdown with Fedor Emelianenko at Affliction: "Trilogy" on Aug. 1 — returned a positive "B" sample on Friday (July 31) according to the California State Athletic Commission (CSAC), all but confirming his initial test result from last month.
Barnett’s positive test led to Affliction MMA’s house of cards to come crashing down, calling it quits as a fight promoter and returning to the UFC as a corporate sponsor with its clothing brand. Several intriguing fights were scrapped as a result, forcing fighters to search for work elsewhere … Barnett included.
The former PRIDE and UFC star issued a press release earlier this week calling into question the integrity of those results alleged by the CSAC -- who does have a fairly sordid history dating back to the Sean Sherk scandal -- and beyond.
From his official press release:
Mr. Barnett was shocked at these allegations and was extremely disappointed to learn that Affliction had made the hasty decision to cancel the August 1st event in its entirety. Mr. Barnett vehemently denies intentionally ingesting any banned substances in preparation for the August 1st fight and he is looking forward to presenting his case to the California State Athletic Commission.
Barnett indicated that he intends to appeal this most recent steroid finding with the CSAC but was likely counting on his second "B" sample to help dispute the initial positive result.
In light of this new development, Barnett will not be eligible to reapply for a license to fight in the United States for at least a year, forcing him to remain exiled in Japan until then. With a Sengoku heavyweight grand prix looming and a successful wrestling career, however, it may not be too difficult to find work.
Keep in locked on MMAmania.com as we’ll let you know more on Barnett’s future when it’s announced.